Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2011

May 3, 2011

32227_dirs_2011-05-03_01ec3a7b-8b21-4876-a4d1-42a0065acad1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEOGENOMICS INC (NGNM.OB)
CIK: 0001077183
Period of Report: 2011-05-03

Reporting Person: Johnson Kevin C (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 66667 Direct
Common Stock 24000 Direct

Footnotes

F1: On April 27, 2011 the Board of Directors approved and granted a restricted stock award of 24,000 shares of NeoGenomics common stock. The terms of the award call for 2,000 shares to vest on the last day of the next 12 quarters starting on June 30, 2011 as long as Mr. Johnson remains a Director of the Company.